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Penicillin-binding protein 5 (PBP 5) of Escherichia
coli functions as a D-alanine carboxypeptidase (CPase),
cleaving D-alanine from the C terminus of cell wall pep-
tides. Like all PBPs, PBP 5 forms a covalent acyl-enzyme
complex with -lactam antibiotics; however, PBP 5 is
distinguished by its high rate of deacylation of the acyl-
enzyme complex (t1⁄2  10 min). A Gly
1053 Asp mutation
in PBP 5 markedly impairs deacylation with only minor
effects on acylation, and abolishes CPase activity. We
have determined the three-dimensional structure of a
soluble form of wild-type PBP 5 at 1.85-Å resolution and
have also refined the structure of the G105D mutant
form of PBP 5 to 1.9-Å resolution. Comparison of the two
structures reveals that the major effect of the mutation
is to disorder a loop comprising residues 74–90 that sits
atop the SXN motif of the active site. Deletion of the
74–90 loop in wild-type PBP 5 markedly diminished the
deacylation rate of penicillin G with a minimal impact
on acylation, and abolished CPase activity. These effects
were very similar to those observed in the G105D mu-
tant, reinforcing the idea that this mutation causes dis-
ordering of the 74–90 loop. Mutation of two consecutive
serines within this loop, which hydrogen bond to Ser110
and Asn112 in the SXN motif, had marked effects on
CPase activity, but not -lactam antibiotic binding or
hydrolysis. These data suggest a direct role for the SXN
motif in deacylation of the acyl-enzyme complex and
imply that the functioning of this motif is modulated by
the 74–90 loop.
Bacterial cell wall peptidoglycan surrounds the cell and is
essential for proper maintenance of cellular morphology and
cell viability. In Escherichia coli, cell walls are composed of a
repeating disaccharide, N-acetylglucosamine--1,4-N-acetyl-
muramic acid, in which the muramic acid residues are substi-
tuted with the pentapeptide, L-Ala-D--Glu-m-DAP-D-Ala-D-Ala
(where m-DAP  meso-diaminopimelic acid). During pepti-
doglycan synthesis, disaccharide-pentapeptide units are poly-
merized onto nascent glycan chains (transglycosylation) and
the peptide chains from different glycan strands are cross-
linked (transpeptidation) by transpeptidases known as penicil-
lin-binding proteins or PBPs.1 Cross-linking of the peptide
chains confers rigidity to the peptidoglycan and viability to the
bacterial cell. The related carboxypeptidases, which hydrolyze
the C-terminal D-Ala moiety from the peptide chain, may mod-
ulate the degree of cross-linking.
In E. coli at least 10 PBPs have been identified. These
enzymes fall into two categories: the high molecular mass
PBPs, which are essential for cell viability and catalyze
transpeptidase and sometimes transglycosylase activity, and
the low molecular mass PBPs, which are non-essential and
catalyze D,D-carboxypeptidase (CPase) and sometimes D,D-en-
dopeptidase activity (1). Regardless of the type of PBP, all of
these enzymes react with peptide substrates and -lactam an-
tibiotics by a similar mechanism. The initial step in the reac-
tion of PBPs with their peptide substrates is a nucleophilic
attack of the D-Ala-D-Ala peptide bond by a conserved serine
residue, leading to acylation of the serine hydroxyl side chain
and the concomitant release of the C-terminal D-Ala. In the
subsequent deacylation step, the acyl-enzyme complex can re-
act with either an amino group (from m-DAP) of another pep-
tide to form a cross-link (transpeptidation) or it can react with
water to release the peptide (carboxypeptidation). Penicillin
and other -lactam antibiotics inactivate these enzymes by
mimicking the structure of the D-Ala-D-Ala C terminus of the
peptide chain (2, 3) and reacting with the same serine nucleo-
phile to form an analogous acyl-enzyme complex (4). Unlike the
complex formed with peptide substrates, however, the -lac-
tam-PBP complex is long-lived and renders the enzyme
inactive.
PBPs and other penicillin-interacting enzymes (e.g. class A
-lactamases) are characterized by a set of conserved motifs
that are clustered in their respective active sites (5). These
motifs include the Ser-X-X-Lys (SXXK) tetrad that contains the
serine nucleophile, the Ser-X-Asn (SXN) triad, and the Lys-
Thr(Ser)-Gly (KTG) triad. In all serine-based PBPs and -lac-
tamases of known structure, these motifs adopt a strikingly
similar conformation to the extent that the active site of one
PBP or -lactamase can look very much like another. In addi-
tion to these three motifs, class A -lactamases have a fourth
motif, Glu-X-X-X-Asn, present on the so-called  loop, that is
responsible for the extremely high rates of deacylation of the
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antibiotic--lactamase complex (6–8). Despite a wealth of
structural and biochemical data, a consensus on the definitive
mechanism of catalysis in -lactamases has yet to emerge.
Nevertheless, the picture of catalysis by -lactamases is much
clearer than in the related PBPs.
To further our understanding of both acylation and deacyla-
tion in PBPs and to examine their mechanistic similarities with
-lactamases, we have focused on PBP 5 from E. coli. PBP 5 is
one of the best characterized PBPs and provides an excellent
system in which to study the catalytic mechanism of penicillin-
interacting enzymes (9–11). PBP 5 is the most abundant PBP
in E. coli and catalyzes the major D-alanine carboxypeptidase
activity in vivo (12). Although it is not essential for cell viabil-
ity, recent studies have shown that PBP 5 is required for proper
cell morphology in E. coli missing certain PBPs (13) and that it
may have a role in cell division (14). PBP 5 is unusual among
PBPs in that it catalyzes a respectable -lactamase activity
(t1⁄2  10 min at pH 7.0) (15, 16). A deacylation-defective mu-
tant of PBP 5 containing a Gly105 to Asp mutation (termed PBP
5) was identified from a screen of bacterial strains lacking
carboxypeptidase IA activity (17, 18). Kinetic studies demon-
strated that PBP 5 had near normal acylation rates with
penicillin G, but displayed a 30-fold decrease in the rate of
deacylation of the penicilloyl-PBP 5 complex (16, 19). Recently,
we reported the crystal structure of PBP 5 (20), which revealed
a conventional arrangement of active site motifs but, in the
absence of the wild-type structure, provided few clues regard-
ing the underlying reason for the defect in deacylation. In this
paper we present the structure of wild-type PBP 5 solved to
1.85-Å resolution. This structure is compared with that of PBP
5 now refined to the higher resolution of 1.9 Å. The principal
difference in the wild-type structure is the ordering of a loop
near the active site comprising residues 74–90, leading to the
hypothesis that the disordering of this loop in the mutant
enzyme is responsible for its markedly decreased deacylation
rate. Kinetic data from mutants in which this loop was re-
moved are consistent with this hypothesis. We also identify two
conserved serine residues on this loop that are important for
CPase activity.
MATERIALS AND METHODS
Crystallization—A soluble form of wild-type PBP 5 missing its cleav-
able signal sequence was expressed in the cytoplasm of E. coli BL21*
cells (Invitrogen, Carlsbad, CA) and purified by ampicillin affinity chro-
matography as described previously (16). For crystallization experi-
ments the protein was concentrated to 5.5 mg/ml in 20 mM Tris, pH 7.5,
containing 30 mM NaCl and 3 mM -mercaptoethanol. Wild-type PBP 5
did not crystallize under the same conditions as those used for PBP 5
(20) and so a new search for conditions was undertaken. Initial trials
used the vapor diffusion hanging drop technique in which 3 l of protein
was mixed with 3 l of well solution. A wide variety of conditions were
tested, including Crystal Screens I and II (Hampton Research, Laguna
Niguel, CA). PBP 5 was purified and crystallized according to previ-
ously established conditions (16, 20).
Data Collection—Crystals of both wild-type and G105D mutant PBP
5 were cryo-protected by passage through their respective stabilization
solutions (wild-type PBP 5: 8% PEG 400, 50 mM Tris-HCl, pH 8.0; PBP
5: 20% PEG 4000, 100 mM Tris, pH 7.0) containing increasing concen-
trations of glycerol, in 2% increments, up to a maximum of 25%. At each
step the crystals were soaked for 5–10 min except at the final step
where the crystals were soaked overnight. Data were collected on a
RAXIS-IV imaging plate system mounted on an RU-H3R x-ray
generator operating at 50 kV and 100 mA and fitted with Osmic Con-
focal Optics (Rigaku/MSC, The Woodlands, TX). For the wild-type crys-
tals, the crystal-to-detector distance was set at 140 mm and data were
collected in 0.5o oscillation frames with an exposure time of 5 min per
frame. A total of 215o of data were collected. For PBP 5 crystals, the
crystal-to-detector distance was 150 mm and data were collected in
1o-oscillation frames with an exposure time of 5 min per frame. A total
of 200o of data were obtained. Both data sets were processed with
CrystalClear (21).
Structure Determination and Refinement—The starting model for
both refinements was the previous 2.3-Å structure of PBP 5 that had
been refined against data obtained at room temperature (20). The
structure of wild-type PBP 5 was solved by molecular replacement
using AMoRe (22) with a search model of PBP 5 in which Asp105 had
been replaced by glycine. Initially, both models were refined with
XPLOR (23), and included several rounds of rigid body refinement, but
later rounds used REFMAC5 (24). Manual refitting of the structures
was performed as necessary with O (25). Water molecules were included
as they became visible in both the ( Fo  Fc ) and 2( Fo  Fc ) electron
density maps and if they had at least two potential hydrogen bonding
partners. The quality of the models was assessed by PROCHECK (26)
and superimpositions were performed using LSQKAB (27). The coordi-
nates and structure factors for the wild-type PBP 5 (1NZO) and PBP 5
(1NJ4) structures have been deposited with the Protein Data Bank.
Construction and Purification of PBP 5 Variants—Constructs of PBP
5 were made in which residues 72–92 were deleted, termed “loop out”
(LO). These constructs were made in both wild-type PBP 5 (PBP 5-LO)
and in the G105D mutant (PBP 5-LO). PBP 5-LO was constructed by
4-primer PCR as described previously (28). The outside primers were
complementary to sequences surrounding the multiple cloning site in
the pT7-7K vector (29). The LO-down internal primer was complemen-
tary to codons 64–71 and 93–98, inclusive (5-CGGAACCTGCATGC-
CCGGGATAGTGACTAAATCAGTTTCTT-3), whereas the LO-up in-
ternal primer (5-CCGGGCATGCAGGTTCCG-3) was complementary
to codons 93–98. In the first round of PCR, pT7-PBP 5 was amplified
with pT7-up and LO-down and with pT7-down and LO-up. Following
the first round of PCR, the two fragments were isolated and added to a
new tube with the outside primers only, and PCR was carried out as
before. The overlapping regions allowed for the annealing of the two
fragments and the full-length gene missing codons 72–92 of the mature
PBP 5 sequence was generated. The final PCR product was digested
with XbaI and HindIII and ligated into similarly digested pT7-7K to
produce pT7-PBP 5-LO. To construct pT7-PBP 5-LO, the XhoI-SphI
fragment encompassing the 5 end of the gene up to codon 94 of pT7
PBP 5-LO was ligated with the SphI-BglII fragment from pT7-PBP 5
containing the G105D mutation and the BglII-XhoI vector fragment
from pT7-7K. Individual mutations were constructed in a similar man-
ner and cloned into the same vector as for the loop-out constructs. All
constructs were verified by sequencing. Following transformation of the
vectors into BL21* cells, the mutant proteins were purified by ampicil-
lin affinity chromatography as described for PBP 5 and PBP 5 (16).
Kinetic Analysis of the Interaction of PBP 5 Variants with [14C]Peni-
cillin G and Peptide Substrate—The reaction mechanism for the inter-
action of PBPs with peptide and -lactam antibiotics is,







E  P (Eq. 1)
where, K  (k1  k2)/k1, ES is the non-covalent Michaelis complex,
E-S is the covalent acyl-enzyme complex, and P is the released product.
The constant k2/K, which describes the formation of the acyl-enzyme
complex (E-S) at low (subsaturating) concentrations of -lactam anti-
biotics, was determined from time courses of the formation of E-S with
[14C]penicillin G essentially as described (30). PBP 5 (48 g; 1.2 nmol)
was diluted into 150 l of binding buffer (50 mM sodium phosphate, pH
7.0, 10% glycerol) and mixed with an equal volume of 100 M [14C]peni-
cillin G in binding buffer. At timed intervals, 20-l aliquots were re-
moved, mixed with 5 ml of 5% trichloroacetic acid (w/v), and incubated
on ice for 15 min. The acidified proteins were passed through number 30
glass fiber filters (Schleicher and Schuell, Keene, NH) and the filters
were washed twice with 5 ml each of 1% trichloroacetic acid, 33%
methanol. The filters were then air dried, placed in scintillation vials
with 3 ml of Scinti-safe scintillation fluid (Fisher Scientific, Pittsburg,
PA), and counted.
k3 values were determined from semi-log plots of the % [
14C]penicillin
G remaining versus time. PBP 5 proteins (11–37 g; 0.28–0.92 nmol)
were diluted into 150 l of binding buffer and mixed with an equal
volume of 100 M [14C]penicillin G for 10 min at 30 °C. At t  0,
penicillin G was added to 3 mM, and the amount of radioactivity re-
maining covalently bound to the protein was determined by removing
20-l aliquots at various times and quantitating the amount of bound
[14C]penicillin G as described above. The t1⁄2 values were determined
from the plots and converted to k3 values by dividing the t1⁄2 in seconds
into 0.693.
CPase assays were carried out with the peptide N,N-diacetyl-L-Lys-
D-Ala-D-Ala and the amount of hydrolysis of the ultimate D-alanine
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residue was quantitated with the spectrophotometric microtiter plate
protocol described by Gutheil et al. (10). Assays contained from 0 to 10
mM peptide and 0.83 M enzyme, with the exception that PBP 5, PBP
5-LO, and PBP 5-LO were also tested at 8.3 M.
RESULTS
Structure Determination—Crystals of wild-type PBP 5 were
obtained over wells containing 8% PEG 400, 100 mM Tris, pH 8.0.
This condition is considerably different from that for PBP 5 (20%
PEG 4000, 50 mM Tris, pH 7.0 (16)) and indicates some difference
in the protein structure. Diffraction studies revealed that the
crystals belonged to space group C2 with cell dimensions a 
109.4 Å, b  50.3 Å, c  84.5 Å, and   120.9o. Electron density
maps showed that the region between residues 74 and 90, which
is absent in the structure of PBP 5 because of apparent flexibil-
ity, is ordered in the wild-type structure. The R factor of the final
model is 20.9% (Rfree  24.5%).
For the purposes of structure comparison a new data set
under cryo conditions was obtained from crystals of PBP 5.
This resulted in a slight improvement in resolution (from 2.3 to
1.9 Å) compared with previous data collected at room temper-
ature (20), but a significant improvement in completeness and
redundancy. The cell dimensions under cryo conditions were
a  b  50.2 Å and c  136.8 Å, which differs principally from
the room temperature cell through a 3.5-Å reduction in the c
dimension. The structure was refined against the 1.9 Å data to
a final R factor of 20.9% (Rfree  24.4%). Compared with the
room temperature structure, residues 85–90 are now visible in
the electron density map but residues 74–84 remain disor-
dered. In both structures difficulty was encountered in fitting
the region 154–157 because this appears to exhibit some dis-
ordering, thus weakening the electron density. The data collec-
tion and final refinement statistics of both models are shown in
Table I.
Structure Description—The overall structure of wild-type
PBP 5 exhibits the same fold as that previously described for
PBP 5 (20). Briefly, PBP 5 is composed of two domains that are
oriented approximately at right angles to each other (Fig. 1A).
Domain 1, which is a transpeptidase-like domain typical of
penicillin-interacting enzymes, comprises a five-stranded anti-
parallel  sheet packed on both sides by  helices. Domain 2 is
unique to PBP 5 and is formed by a sandwich of two anti-
parallel  sheets, one three-stranded and the other two-
stranded. The active site of PBP 5 is located at the interface of
the five-stranded anti-parallel  sheet and the large  helical
cluster within domain 1.
Structure Comparison—The common main chain atoms of
domain 1 of wild-type PBP 5 and PBP 5 superimpose very
closely with an r.m.s. deviation of 0.88 Å, indicating that the
mutation has little effect on the overall structure. After super-
imposition a slight shift in the relative position of domain 2 is
observed (Fig. 1A). This difference arises from a hinging motion
centered at the domain boundary (residue 262) resulting in a
relative 6-Å shift of residues at the base of domain 2. The
shifted position of domain 2 is likely the result of crystal pack-
ing interactions, which are different in the two structures. In
the wild-type structure the tip of domain 2 packs against the
74–90 loop, whereas in PBP 5 this region is largely exposed.
Superimposition reveals two regions within domain 1 in
which significant structural differences are observed between
the wild-type and mutant enzymes: 1) residues 74–90, and 2)
residues 190–193 of the 7-8 loop (Fig. 1B). Slight differences
are also seen in the so-called -like loop, but because the
electron density for this region is weak in both structures, this
is most likely because of the difficulties in fitting the model.
74–90 Region—In the structure of PBP 5 reported previ-
ously, which was solved using data collected at room tempera-
ture, the region between residues 74 and 90 (inclusive) was not
visible in the electron density map (20). In the new structure of
PBP 5 refined against data collected under cryo conditions,
residues 85–90 are now visible and adopt an irregular loop
structure, whereas residues 74 to 84 remain disordered (Fig.
1B). The crystallographic B factors for residues 85–90, how-
ever, are high (in the 50s) and some of the side chains are
poorly resolved, indicating a high degree of flexibility. The
increased ordering of residues 85–90 in PBP 5 is likely because
of the improvement in the quality of data obtained under cryo-
genic conditions. In contrast, the entire region encompassing
74–90 in the wild-type structure is highly ordered and has
refined with low B factors (in the 30s). The secondary structure
of this region, which is stabilized by numerous non-bonding
interactions to the surrounding protein, is mostly an irregular
loop but starts with a helical turn and finishes in an extended
conformation. In the middle is a striking “zig zag” motif in
which there are tight turns made by Pro81 and Gly85. Interest-
ingly, residues 85–90 adopt a different fold in each structure
with the divergence beginning at residue 90 (reverse direction)
(Fig. 1B). In the wild-type structure this loop remains close to
the protein domain, whereas in PBP 5 these residues point out
toward solvent.
190–193 Loop—The only other region that is altered signif-
icantly between the two structures is the connecting loop be-
tween 7 and 8, comprising residues 190–193 (Fig. 1B). In the
wild-type structure, this loop is displaced slightly away from
the active site because of the presence of Met89, which is central
to the hydrophobic core in this region (see below). In the PBP 5
structure, the absence of this residue has enabled Phe190 to
move in and fill the void in the hydrophobic core.
TABLE I
X-ray diffraction data and model refinement statistics for wild-type
and G105D mutant PBP 5 (PBP 5) structures
Figures within brackets are for the outer resolution shells.
Wild-type (1NZO) PBP 5 (1NJ4)
Data collection





a (%) 6.0 (32.2) 7.3 (35.8)
Completeness (%) 93.4 (67.8) 98.7 (88.4)
I/I 7.4 (2.0) 7.1 (1.8)
No. of observations 141727 178730
No. of unique reflections 31624 29772
Redundancy 4.5 6.0
Refinement
Resolution range (Å) 15.0-1.85 15-1.90
No. of reflections used in refinement 28942 28198
Reflections in Free R set (%) 5 5
No. of non-hydrogen protein atoms 2718 2649
No. of water molecules 190 219
R factor (%) 20.9 20.9
R work (%) 20.7 20.7
R free (%) 24.5 24.4
Overall Biso (Å
3) 31.9 29.3
Mean B factor (main chain) (Å3) 30.5 27.9
R.m.s. deviation in main chain B
factor (Å3)
0.56 0.51
Mean B factor (side chains) (Å3) 32.7 29.8
R.m.s. deviation in side chain B
factors (Å3)
1.59 1.27
Mean B factor (waters alone) (Å3) 37.5 34.9
R.m.s. deviation for bond length (Å) 0.013 0.007




Residues in most favored region (%) 91.5 92.6
Residues in disallowed regions (%) 0.0 0.0
a Rmerge  	Ii  Im/	Ii, where Ii is the intensity of the measured
reflection and Im is the mean intensity of all symmetry-related reflections.
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Effect of the G105D Mutation—Given that glycine residues
tend to act as helix breakers, it might have been expected that
the 4 helix containing the mutation would terminate earlier in
wild-type PBP 5 than in the mutant PBP 5 structure, thereby
affecting the conformation of the SXN active site motif that
directly follows the 4 helix. Surprisingly, little or no structural
difference in this helix or its residue side chains is seen be-
tween the two structures (Fig. 2). In PBP 5 only the side chain
of Gln109 has moved slightly to avoid a clash with Asp105, which
lies directly below this residue on the helix. In the wild-type
structure, the side chain of Gln109 is within hydrogen bonding
distance of the carbonyl group of Leu88, a contact that is absent
in PBP 5. Instead, the primary effect of the G105D mutation in
PBP 5 is to disrupt a hydrophobic core region. In the wild-type
structure, this core is formed by the hydrophobic faces of 4,
5, 7, 8, and the 74–90 loop (Fig. 3). At the heart of the
hydrophobic core is Met89, with additional contributions of
Phe188, Phe190, Leu91, Leu102, and Ala114. In the PBP 5 struc-
ture, a glycine to aspartic acid mutation at position 105 dis-
rupts this region by projecting directly into the space occupied
by Met89. As a result, Met89 is displaced along with Phe90 and
residues 85–88. The space vacated by Met89 is partially occu-
pied by Phe190, hence the movement of residues 190–193.
A buried aspartate (Asp113) is also present within the hydro-
phobic core and each of its  oxygen is within hydrogen bonding
distance of three amide nitrogens (Fig. 4). O1 of Asp113 con-
tacts the amides of residues 89–91, whereas O2 contacts the
amides of 89, 113, and 114. The rarity of buried aspartates
together with its role in stabilizing the structure of the 74–90
region suggests that the conformation of this loop is critical for
FIG. 1. Comparison of the structures of wild-type PBP 5 and PBP 5-G105D mutant (PBP 5). A, stereo representation of the
superimposition of the overall folds of the wild-type (green) and PBP 5 mutant (orange) structures. The arrows denote the major regions of
structural difference in the two proteins, located around the active site at the top and the base of the molecule in domain 2. B, stereo representation
showing structural differences in the active site region. The secondary structure is labeled according to Davies et al. (20). The starting and ending
points of the disordered region in PBP 5 are denoted by the small spheres at the C atoms of residues 73 and 91, and are colored orange in PBP
5, and green in wild-type. To emphasize the disparity between the two structures, the position of Gly85 is also shown in the wild-type structure
(green sphere), which is located far from its counterpart in PBP 5. For reference, C atoms of important active site residues are shown as small
red spheres. This figure was prepared using MOLSCRIPT (36) and RASTER3D (37).
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function. As discussed below, the change in conformation of
residues 85 to 90 and the disordering of residues 74–84 is
likely responsible for the altered kinetic properties of PBP 5.
Active Site Comparison—A side-by-side comparison of the
two active sites is shown in Fig. 5. The key residues are as
follows: Ser44 and Lys47 of the Ser-X-X-Lys tetrad are located
on one face of the 2 helix, Ser110 and Asn112 of the Ser-X-Asn
triad are present on the loop connecting helices 4 and 5, and
Lys213, one of three residues in the Lys-Thr(Ser)-Gly triad,
extends into the cavity. One other residue of note is Arg198,
which is on the loop at the top of the cavity. It is immediately
obvious that the principal change in the active site in the
wild-type structure results from the ordering of the loop en-
compassing residues 74–90 (shown as a red loop in Fig. 5A).
This loop is oriented over the active site and interacts with the
SXN motif via two serine residues, Ser86 and Ser87, both of
which are highly conserved in PBP 5-related CPases (20). Ser87
makes two potential hydrogen bonds, one between its side
chain -oxygen and the carbonyl oxygen of Gln109 and the other
from its carbonyl group to N2 of Asn112 (Figs. 4 and 5). There
is also a potential hydrogen bond between the -oxygen of Ser86
and N2 of Asn112. Thus Asn112 is contacted by Ser86, Ser87, and
Lys47. In PBP 5 these serine-mediated interactions are absent
because of the disordering of the 74–90 loop.
The relative positions of the residues comprising the con-
served active site motifs of penicillin-interacting enzymes are
essentially identical. The network of hydrogen bonding inter-
actions observed in the PBP 5 structure (20), those between
Ser110 and Lys213, and from Lys47 to Asn112 and the carbonyl of
His151, are all retained. One notable difference arises through
a rotation of Ser44, such that in the PBP 5 structure this
residue no longer forms a hydrogen bond with Lys47 (Figs. 5
and 6). The electron density for this residue in both structures,
however, indicates some rotational freedom of the serine side
chain. Arg198 is also oriented slightly different in the two struc-
tures because the presence of Ser87 on the 74–90 loop has
pushed this residue upwards in the wild-type enzyme. The
likely impact of these structural differences on catalytic func-
tion is discussed below.
Relatively few water molecules are observed in either active
site and few are structurally conserved. The most significant
water molecule is one within hydrogen bonding distance of
Ser44 in both structures. In PBP 5, a water molecule (Wat130)
bridges the  oxygen of Ser44 and the carbonyl group of His216.
In the wild-type enzyme, a similar water molecule is present
(called Wat89) but because Ser44 is rotated slightly with respect
to PBP 5, the water is too distant to hydrogen bond with
His216.
Functional Analysis of PBP 5 Mutants and Variants Lacking
Residues 72–90—As discussed above, the structure of wild-type
PBP 5 reported here differs from PBP 5 primarily by the
ordering of the region encompassing residues 74–90. This re-
sult suggests that the functional phenotype of PBP 5, i.e. a
markedly impaired deacylation rate and lack of CPase activity,
is due directly to the disruption of this region by the G105D
mutation. To test this hypothesis and to determine the role of
the 74–90 loop in the activity of PBP 5, we made constructs in
which this loop was deleted. In the wild-type structure, the 
carbons of residues 71 and 93 are separated by 4.7 Å. Because
the residue following Pro93 is a glycine, we predicted that
FIG. 2. Superimposition of PBP 5 wild-type and PBP 5 struc-
tures in the region of the mutation. Both backbone and side chain
residues show very little change in helix 4 containing the G105D
mutation. The one exception is the side chain of Gln109, which moves
away in the mutant structure to accommodate the presence of the Asp
mutation (see text for details). The color scheme is identical to Fig. 1.
This figure was prepared using MOLSCRIPT (36) and RASTER3D (37).
FIG. 3. Stereo representation of the hydrophobic core region in wild-type PBP 5. This region is formed in part by the 74–90 loop, which
is altered in PBP 5. In this superimposition the wild-type structure is shown as solid bonds, whereas the PBP 5 structure is shown as dashed lines.
The  carbon positions are shown as dots and are labeled. In areas where the structures diverge, the equivalent atoms in PBP 5 are also labeled.
This figure was prepared using MOLSCRIPT (36).
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fusing Ile71 to Pro93 would promote the formation of a -turn
with minimal disturbance to the overall structure of the
protein.
PBP 5, PBP 5, and both proteins missing residues 72–92
(termed PBP 5-LO and PBP 5-LO, respectively) were ex-
pressed in E. coli and purified by ampicillin affinity chroma-
tography. Like PBP 5 and PBP 5, the loop-out constructs were
soluble and bound stoichiometric amounts of [14C]penicillin G
(data not shown). Internal deletion of residues 72–92 had only
a small effect on the specificity constant for penicillin G. Wild-
type PBP 5 had a k2/K of 390 M
1 s1 with [14C]penicillin G,
whereas PBP 5, PBP 5-LO, and PBP 5-LO had k2/K values

4- to 6-fold lower (Table II). Moreover, the k2/K values for the
two loop-out constructs were very similar to the k2/K constant
for PBP 5, and effects of the loop-out were not additive with
the G105D mutation.
In contrast to the small effect on the acylation rate constants
in the loop-out constructs, there was a much greater effect on
the deacylation rates of the penicilloyl-PBP 5 complex. PBP 5
and PBP 5 hydrolyzed bound [14C]penicillin G with rate con-
stants of 78  104 s1 (t1⁄2  14.4 min) and 3  10
5 s1 (t1⁄2 
380 min), respectively, which were very similar to the con-
stants reported previously (16, 31) (Table II). Consistent with
our hypothesis, PBP 5-LO had a deacylation rate constant of
3.7  105 s1 (t1⁄2  315 min), very similar to the k3 rate
constant of PBP 5. Thus, deletion of residues 72–92 in PBP 5
had essentially the same affect on deacylation as mutation of
Gly105 to Asp. When residues 72–92 were deleted in PBP 5, the
k3 constant decreased another 3-fold to 1.1  10
5 s1 (t1⁄2 
1050 min).
Another characteristic of PBP 5 is its lack of CPase activity. If
the major effect of the G105D mutation is the disruption of the
region encompassing residues 74–90, we would expect that the
loop-out constructs would also lack CPase activity. Indeed, both
PBP 5-LO and PBP 5-LO lack any detectable CPase activity
with N,N-diacetyl-L-Lys-D-Ala-D-Ala, even at peptide concentra-
tions as high as 10 mM and enzyme concentrations as high as 8
M. The loss of CPase activity in both PBP 5 and PBP 5-LO could
result from one of two scenarios: 1) the peptide forms an acyl-
enzyme complex but is unable to undergo deacylation (i.e. no
turnover), or 2) the peptide is incapable of forming an acyl-
enzyme complex, either because of a lack of substrate binding or
acylation. To distinguish between these two possibilities, we in-
cubated PBP 5 and PBP 5-LO with or without 20 mM peptide
substrate at pH 8.5 for 20 min prior to assessing their acylation
rate with [14C]penicillin G. There was no difference in the k2/K
constants between buffer and peptide preincubation conditions
(data not shown), precluding the possibility that the peptide
FIG. 4. Stereo representation of the interactions made between the 74–90 loop (colored purple) and the SXN active site motif
(colored green) in PBP 5. In this view the active site is at the bottom. Three residues are particularly important in this interface: Asp113 makes
several interactions with the backbone of residues 89–91, 113, and 114, and serines 86 and 87 interact directly with Ser110 and Asn112 of the SXN
motif. Potential hydrogen bonds are shown as dashed lines. Oxygen and nitrogen atoms are shown as red and blue bonds, respectively. This figure
was prepared using MOLSCRIPT (36) and RASTER3D (37).
FIG. 5. A side-by-side comparison of
active site residues in (A) wild-type
and (B) G105D mutant PBP 5. The ac-
tive site is formed by five structural ele-
ments. Three of these contain the well
known sequence motifs typical of penicil-
lin-interacting enzymes: the SXXK motif
(yellow), the SXN motif (green), and the
KTG motif (orange). Other motifs are spe-
cific to PBP 5 and close homologues: the
-like loop (blue), a loop containing Arg198
(purple) and the 74–90 region (red). Note
the absence of the latter in PBP 5.
Dashed lines indicate potential hydrogen
bonds. This figure was prepared using
MOLSCRIPT (36) and RASTER3D (37).
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substrate forms a stable acyl-enzyme complex.
We also investigated the role of the two serine residues
(Ser86 and Ser87) in the 74–90 loop, which are conserved in
PBP 5-related CPases (20). As discussed above, these residues
sit atop the SXN active site motif and contact both the main
chain and side chain amides of Asn112 and the main chain
carbonyl of Gln109 (Fig. 4). Ser86 and Ser87 were mutated to
alanine, and the enzymatic and kinetic activities of the result-
ing proteins were determined. Mutation of these serine resi-
dues either individually or together had little effect on the
interaction of the protein with [14C]penicillin G (Table II). The
acylation rate constants of the mutants were nearly identical to
wild-type PBP 5, suggesting these residues serve no role in
binding or acylation of -lactam antibiotics. The mutants
showed only a slight decrease in k3 with [
14C]penicillin G,
between 1.4- and 2.6-fold lower than wild-type (Table II). In
contrast, all the serine mutants showed a much greater de-
crease (between 8- and 16-fold) in the kcat/Km constants for
CPase activity measured with peptide substrate. These data
suggest that these two serine residues are important for CPase
activity of PBP 5.
DISCUSSION
Our structural studies of PBP 5 began with PBP 5-G105D
(called PBP 5), a deacylation-defective mutant of PBP 5 (20).
This structure revealed that PBP 5 has two domains: a peni-
cillin-binding domain showing high structural similarity to
other PBPs and class A -lactamases, and a second domain of
unknown function. In the absence of structural information for
the wild-type enzyme, however, the mutant structure provided
little insight into how the G105D mutation leads to a catalytic
deficiency in deacylation. In this study, we present the struc-
ture of wild-type PBP 5 determined to 1.85-Å resolution and
compare it with the previous structure of PBP 5 now refined to
1.9-Å resolution. The striking difference between the two struc-
tures is the order/disorder in residues 74–90, suggesting that
this region is critical for catalytic function. This hypothesis is
supported by the apparent precision in its structure and by its
close proximity to the active site. Most striking is the presence
of a buried aspartate (Asp113) that orients the loop via interac-
tions with the amide nitrogens of residues 89–91, an interac-
tion that is lost in PBP 5 (see Fig. 4). Buried aspartates are
rare in proteins and their presence usually signifies a region
important for function. Another unusual feature is the zig zag
structure that immediately precedes Ser86 and Ser87.
Disordering of the loop encompassing residues 74–90 in PBP
5 could arise in two ways: 1) through differences in crystal
packing between the two crystal forms or 2) as a direct effect of
the G105D mutation. In essence, this is a chicken and egg
problem. Did the crystal packing in the P32 form afford the loop
greater flexibility, leading to its disorder, or did the mutation
disrupt the loop and thereby prevent crystallization of PBP 5
in the C2 space group? Several lines of evidence suggest the
latter explanation is most likely. First, the wild-type protein
does not crystallize under the same conditions obtained for
PBP 5, which suggests that the protein structure itself deter-
mines the crystal form and not vice versa. Second, examination
of the wild-type structure shows an obvious mechanism for how
the mutation site disrupts the 74–90 loop. In the mutant en-
zyme Asp105 displaces Met89 from a hydrophobic core and in
doing so alters the loop structure and hence the crystallization
behavior of the protein. Finally, removal of the loop by deleting
the codons encoding residues 72–92 results in a protein with a
nearly identical functional phenotype as PBP 5-G105D, sug-
gesting that the disordering of the loop leads directly to the
decrease in deacylation of [14C]penicillin G and abrogation of
CPase activity.
Comparison of the PBP 5 and PBP 5-G105D structures does
not reveal an obvious mechanism for the loss of CPase activity
in PBP 5, especially because the 74–90 loop appears too far
removed from the active site to participate directly in catalysis.
One explanation is that PBP 5 retains the ability to bind and
react with peptide and that the loss of CPase activity is because
of the marked decrease in the rate of deacylation, resulting in
the accumulation of covalently bound peptide. However, this is
unlikely because preincubation of PBP 5-LO with peptide had
no effect on the rate of acylation with [14C]penicillin G. A more
likely explanation is that this region is important for peptide
binding (and/or acylation) but to test this will require a complex
of PBP 5 with peptide substrate.
One contributing factor to the loss of peptide binding in PBP
5 and PBP 5-LO may be the movement of Arg198, which sits at
the top of the active site (Fig. 5). In PBP 5, Arg198 forms a
hydrogen bond with the carbonyl of Gln109, whereas in the
wild-type enzyme it is hydrogen-bonded to Ser87. The recent
structure of the Streptomyces R61 D,D-peptidase in complex
with its peptide substrate revealed a strong interaction be-
tween Arg285, the equivalent of Arg198 in the D,D-peptidase, and
the C-terminal carboxylate of the peptide substrate (32). Thus,
the altered position of Arg198 in PBP 5 (and presumably PBP
5-LO) may hamper its ability to interact with the C terminus of
the peptide substrate in PBP 5, leading to a marked decrease in
substrate binding and CPase activity.
FIG. 6. Superimposition of three active site residues from
wild-type and G105D mutant structures of PBP 5. Atoms are
colored by type in which oxygens are red, nitrogens are blue, and
carbons are dark gray. Bonds are colored green for wild-type and orange
for G105D mutant. Note the minimal difference in the conformation of
Asn113, even though in wild-type PBP 5 this residue interacts with
serines 86 and 87 (not shown but to the left). This figure was prepared
using MOLSCRIPT (36) and RASTER3D (37).
TABLE II
Kinetic constants for the interaction of PBP 5 variants with
[14C]penicillin G and peptide substrate
k2/K and k3 values were determined as described under “Materials
and Methods” and are the average of three to seven independent ex-
periments. The kcat/km values were determined with the synthetic pep-
tide substrate, N,N-diacetyl-L-Lys-D-Ala-D-Ala.
Protein k2/K t1/2 k3 kcat/Km
M
1 s1 min s1  105 M1 s1
PBP 5 390  80 14.4  0.8 78  4 32  5
PBP 5(G105D) 80  14 380  14 3.0  0.1 NDa
PBP 5-LO 73  6 315  14 3.7  0.2 ND
PBP 5-LO 120  10 1050  44 1.1  0.1 ND
PBP 5-S86A 270  20 38  7 32  2 3.9  0.8
PBP 5-S87A 310  30 33  2 35  2 2.0  0.5
PBP 5-S86A,S87A 305  12 20  0.3 58  1 2.6  0.5
a ND, no activity detected.
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Our results shed new light on the mechanism of deacylation
in PBP 5. The wild-type and G105D mutant PBP 5 structures,
together with kinetic analysis of the loop-out constructs, sug-
gest that disordering of the 74–90 loop is the primary reason
for the defect in the rate of hydrolysis of the acyl-enzyme
complex in PBP 5. Furthermore, the precise interaction of this
region with the active site via contacts from serines 86 and 87
to the SXN motif suggests that this motif has a major role in
deacylation of the acyl-enzyme complex. How it does so is
unclear. Its absence or presence makes almost no difference to
the conformation of the SXN motif (Fig. 6), suggesting a subtle
mechanism for the defect in deacylation in PBP 5. Moreover,
mutation of these residues to alanine had no effect on acylation
with -lactam antibiotics and only minor effects on deacylation.
In contrast, we observed a 
10-fold decrease in kcat/Km for
hydrolysis of peptide substrate, clearly implicating these resi-
dues in CPase activity. Interestingly, the functional phenotype
resulting from mutation of these two serine residues in PBP 5
was much less severe than that obtained by deleting the 74–90
loop, which resulted in a 30-fold decrease in deacylation activ-
ity and the total absence of CPase activity. At first glance this
appears to suggest a role for this loop beyond that of orienting
these two serine residues. However, because several of the
hydrogen bonds from these two serines to residues in the SXN
motif emanate from the peptide backbone and would be re-
tained in the mutants, the severity of the functional phenotype
in PBP 5 and PBP 5-LO may simply be because of the absence
of these backbone-mediated interactions.
How then does the SXN motif function in deacylation? The
two obvious candidates for a functional role are Asn112 and
Ser110: Asn112 is contacted directly by both Ser86 and Ser87,
whereas Ser110 is contacted indirectly via interactions from
Ser87 to Gln109 and Gly111 (see Fig. 4). In class C -lactamases
and the D,D-peptidase from Streptomyces R61, the equivalent
residue of Ser110 is a tyrosine and the phenoxide anion of this
residue has been proposed to act as a general base in deacyla-
tion (33–35). For Ser110 in PBP 5 to act in an analogous man-
ner, however, seems unlikely because the pKa of the serine
hydroxyl is too high for this residue to form an anion. The same
argument applies to Asn112 and so it is doubtful that either of
these residues act directly in deacylation. Instead we have
assigned Lys47 as the general base to polarize the hydrolytic
water molecule, which is located next to Ser44 (11, 20). A more
likely role for either Ser110 or Asn112 would be to help orient the
hydrolytic water molecule near Lys47. Asn112 is suitably posi-
tioned immediately adjacent to Lys47 (Fig. 6) and for Ser110, its
side chain could rotate away from Lys213 and toward Lys47 (see
Fig. 5A). Regardless of which residue is involved, it is clear that
the absence of the 74–90 loop in PBP 5 hinders deacylation. To
investigate the role of the 74–90 loop in deacylation further
will require structures of both PBP 5 and PBP 5 covalently
bound to penicillin G in which the hydrolytic water is apparent.
These studies are underway.
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